FDA Inspection 815176 — Summa Health System

Summa Health System — FEI 1571004

The FDA completed an inspection of Summa Health System on January 23, 2013 in Akron, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 23, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Akron, OH (United States)